Patients with severe COVID-19 were treated with antivirals (lopinavir/ritonavir and ribavirin) available only in treatment centers. Thus, the Army Training Hospital (HIA) in Parakou was transformed into an isolation and management center for COVID-19 cases.ĭespite the controversy surrounding the treatment of the disease, Benin's Ministry of Health set up a committee of experts to propose a therapeutic protocol. Since the first wave, several measures have been taken to control the epidemic, including the creation of sites for the management of severe cases. Benin, after recording its first case of COVID-19 in March 2020, faced successively the first, second, third and fourth wave of the epidemic with 27,638 confirmed cases including 163 deaths in December 2022. Witness the controversy surrounding the efficacy of masks, the efficacy of different diagnostic methods and the great controversy surrounding the efficacy of hydroxychloroquine, Ivermectin and other therapeutic methods. ĬOVID-19 has also been the disease of all scientific controversies, whether diagnostic, preventive or curative. This new disease, whose clinical manifestations are polymorphic and non-specific, ranging from a simple flu-like syndrome to a severe and fatal pneumonia, has made even the most developed countries experience a real health nightmare. Thus, it was declared on Maas a pandemic by the World Health Organization (WHO). This disease, due to its rapid spread, very early led to a global health crisis. This is the third coronavirus epidemic after SARS-CoV in 2002–2003 and Middle East Respiratory Syndrome (MERS) in 2012. The second coronavirus infection causing severe acute respiratory syndrome named the coronavirus infectious disease of 2019 (COVID-19) started in Wuhan, Hubei province of China as an outbreak in December 2019. Several factors are associated with the prognosis of the disease. ConclusionĬOVID-19 was a reality in Parakou, with a significant number of severe cases requiring hospitalization. Predictors of death were high blood pressure, presence of signs of severity, high-concentration mask ventilation used, and elevated transaminases. Recovery was noted in 151 (76.26%) patients. Therapeutically, 95 patients (47.98%) had received the combination of Lopinavir/ritonavir and Ribavirin and 95 others (47.98%) received chloroquine. ResultsĪ total of 198 cases of COVID-19 were identified, 117 of whom were men. The data were analyzed using Stata/MP 14.1 software. This study was approved by the Local Ethical Committee. The variables studied were clinical and paraclinical signs, diagnostic and therapeutic means, evolution under treatment and prognostic factors. Systematic recruitment was used to include all patients hospitalized with COVID-19 from May 8, 2020, to December 31, 2021, whose medical records were available and usable. This was a cross-sectional, descriptive and analytic study. The purpose of this study was to describe the epidemiological, clinical, therapeutic features and identify the predictors of mortality among COVID-19 hospitalized cases in Parakou. COVID-19 is an emerging contagious infection with polymorphic clinical manifestations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |